CKD Bio Corp - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for CKD Bio Corp Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

CKD Bio Corp. The Company's principal activity is the providing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of potassium clavulanates, demethylchlortetracyclines (DMCTs) and rifampicins. It also develops immunosuppressive agents including cyclosporin and tacrolimus, and remedies for diabetes such as acarbose. The Company exports its products to China, the United States, Europe, Southeast Asia, Africa, South America and the Middle East. The Company operates a research laboratory concentrated on the production of therapeutic pharmaceuticals.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report